2024-10-01 - Analysis Report
## CVS Health Corp (CVS) Stock Analysis Report

**1. Performance Overview**

CVS Health Corp (CVS) is a healthcare company that operates retail pharmacies, pharmacy benefit management, and health care services. 

Over the past period, CVS has underperformed the S&P 500 (VOO). Its cumulative return of -31.94% is significantly lower than VOO's 133.28%. This results in a significant divergence of -165.22, representing 1.36 of the maximum historical divergence.

**2. Recent Price Movement**

As of today, CVS is trading at $61.75. It is currently above its 5-day ($58.98), 20-day ($58.00), and 60-day ($58.31) moving averages, suggesting potential upward momentum.

**3. Technical Indicators**

* **RSI (76.04):** The RSI is currently in overbought territory, indicating potential for a correction.
* **PPO (0.62):** The PPO is positive, indicating bullish momentum.
* **Delta_Previous_Relative_Divergence (-1.14):** This negative value suggests a short-term downward trend.
* **Expected_Return (0.0%):** This represents the maximum potential return over the next 5 years, considering current investment.

**4. Recent Earnings Performance**

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

CVS exceeded earnings expectations in the most recent quarter (2024-08-07) with an EPS of 1.83 against an expected EPS of 1.73. However, CVS has shown a recent trend of missing earnings expectations, indicating potential challenges with profitability. 

**5. News and Recent Issues**

**Recent Market Outlook for CVS:** 

The stock has experienced volatility due to factors such as competition in the pharmacy sector, rising healthcare costs, and the impact of the COVID-19 pandemic. However, CVS continues to benefit from a growing aging population and a growing demand for pharmacy services.

**Analyst Opinions and Performance Highlights:**

* **Finbold:** Some analysts see CVS as a strong long-term play due to its diversification in pharmacy services and healthcare. However, concerns remain regarding the company's profitability and the competitive landscape.

**6. Overall Analysis**

CVS is currently trading above its moving averages, suggesting potential upward momentum. However, its recent underperformance compared to the S&P 500 and its overbought RSI raise concerns about a potential correction. While CVS exceeded earnings expectations in the most recent quarter, its trend of missing earnings expectations and the challenging healthcare environment should be considered. The company's diversification and potential for long-term growth are strengths, but investors should monitor its performance and the overall market outlook closely.

**7. Recommendation**

Given the current situation, a cautious approach is recommended. While the stock has potential for growth, the overbought RSI, recent earnings performance, and broader market conditions warrant caution. Investors should consider their individual risk tolerance and investment goals before making any decisions. 
